West Pharmaceutical Services Overview
West Pharmaceutical Services Target Price
Analysts' 12-month price predictions for WST.
Get informed when a big investor buys or sells
+ FollowShare Price
$336.39
Average Target Price
$341.67
1.6% upside
1.6% upside3 analysts in the last 4 months
High: $400 | Low: $310
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-09 | BarclaysLuke Sergott | $400 | 18.9% upside |  |
| 2026-04-27 | Morgan Stanley | $315 |  6.4% downside | |
| 2026-04-27 | Barclays | $310 | 7.8% downside | |
| 2026-02-13 | UBSDan Leonard | $340 | 1.1% upside | |
| 2026-02-13 | Deutsche Bank | $315 | 6.4% downside | |
| 2026-02-13 | BarclaysLuke Sergott | $265 | 21.2% downside | |
| 2026-02-10 | JefferiesDavid Windley | $295 | 12.3% downside | |
| 2026-02-03 | Evercore ISIDaniel Markowitz | $320 | 4.9% downside | |
| 2025-12-01 | Morgan Stanley | $285 | 15.3% downside | |
| 2025-10-27 | Barclays | $325 | 3.4% downside | |
| 2025-10-24 | UBSDan Leonard | $355 | 5.5% upside | |
| 2025-10-24 | Deutsche BankJustin Bowers | $345 | 2.6% upside | |
| 2025-10-23 | Evercore ISIDaniel Markowitz | $390 | 15.9% upside | |
| 2025-10-07 | Evercore ISI | $350 | 4% upside | |
| 2025-10-02 | Barclays | $275 | 18.2% downside | |
| 2025-09-15 | Redburn PartnersJamie Clark | $311 | 7.5% downside | |
| 2025-06-24 | BarclaysLuke Sergott | $245 | 27.2% downside | |
| 2024-11-19 | JefferiesDavid Windley | $393 | 16.8% upside | |
| 2024-02-07 | JefferiesDavid Windley | $536 | 59.3% upside | |
| 2022-12-14 | Deutsche Bank | $250 | 25.7% downside | |
| 2022-11-30 | UBS | $250 | 25.7% downside | |